LEADER 02329nam  2200589   450 
001 9910464764403321
005 20200520144314.0
010   $a0-309-29247-6
035   $a(CKB)3710000000103374
035   $a(EBL)3379237
035   $a(SSID)ssj0001191230
035   $a(PQKBManifestationID)11708378
035   $a(PQKBTitleCode)TC0001191230
035   $a(PQKBWorkID)11219918
035   $a(PQKB)11381147
035   $a(MiAaPQ)EBC3379237
035   $a(WaSeSS)bw9780309292467
035   $a(Au-PeEL)EBL3379237
035   $a(CaPaEBR)ebr10863892
035   $a(OCoLC)923289754
035   $a(EXLCZ)993710000000103374
100   $a20140506h20142014  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aImproving and accelerating therapeutic development for nervous system disorders $eworkshop summary /$fSheena M. Posey Norris [and three others], rapporteurs ; Forum on Neuroscience  and Nervous System Disorders : Board on Health Sciences Policy
210  1$aWashington, District of Columbia :$cNational Academies Press,$d2014.
210  4$dİ2014
215   $a1 online resource (119 p.)
300   $aDescription based upon print version of record.
311   $a0-309-29246-8 
320   $aIncludes bibliographical references.
327   $a""Front Matter""; ""Reviewers""; ""Contents""; ""1 Introduction and Overview""; ""2 Drug Development Challenges""; ""3 Target Identification""; ""4 Target Validation""; ""5 Opportunities to Improve and Accelerate the Drug Development Pipeline""; ""6 Perspectives on Next Steps""; ""Appendix A: References""; ""Appendix B: Workshop Agenda""; ""Appendix C: Registered Attendees""
606   $aDrug development$vCongresses
606   $aDrug approval$vCongresses
606   $aClinical trials$vCongresses
608   $aElectronic books.
615  0$aDrug development
615  0$aDrug approval
615  0$aClinical trials
676   $a615.1
702   $aNorris$b Sheena M. Posey
712 02$aInstitute of Medicine (U.S.)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910464764403321
996   $aImproving and accelerating therapeutic development for nervous system disorders$92291278
997   $aUNINA